Karolinska Development
An investment company that finances and supports innovative life science ventures.
KDEV | ST
Overview
Corporate Details
- ISIN(s):
- SE0002190850 (+1 more)
- LEI:
- 54930011ZA52NKO5W681
- Country:
- Sweden
- Address:
- Nanna Svartz väg 6A, 171 65 Solna
Description
Karolinska Development is an investment company specializing in the life sciences sector. It identifies, finances, and supports the creation and growth of companies developing innovative medical technologies and pharmaceuticals. The firm manages a diversified portfolio of biotechnology and medtech ventures, often originating from academic research, with the goal of developing ground-breaking treatments for severe diseases. Karolinska Development leverages its team's expertise in research, development, and commercialization to guide its portfolio companies, providing both capital and strategic support to advance innovations toward the market.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2013-04-10 07:57 |
Bo Jesper Hansen föreslås som ny styrelseordförande
|
Swedish | 319.4 KB | ||
| 2013-04-02 07:57 |
Preliminary results of a Phase II study indicates that Axelar’s AXL1717 is effi…
|
English | 343.3 KB | ||
| 2013-04-02 07:57 |
Preliminära resultat från en fas II-studie indikerar att Axelars AXL1717 är eff…
|
Swedish | 339.9 KB | ||
| 2013-03-08 07:57 |
Karolinska Development and Rosetta Capital Announce the Closing of their SEK 22…
|
English | 337.6 KB | ||
| 2013-03-08 07:57 |
Karolinska Development och Rosetta Capital annonserar slutförandet av strategis…
|
Swedish | 334.9 KB | ||
| 2013-02-20 07:57 | Swedish | 1.1 MB | |||
| 2013-02-20 07:57 | English | 1.2 MB | |||
| 2013-02-08 07:57 |
Pergamum AB inleder strategiskt samarbete med Cadila Pharmaceuticals Ltd
|
Swedish | 358.6 KB | ||
| 2013-02-08 07:57 |
Pergamum AB announces a strategic collaboration with Cadila Pharmaceuticals Ltd
|
English | 360.8 KB | ||
| 2013-02-04 07:57 |
Karolinska Development startar samarbete med Mayo Clinic
|
Swedish | 320.2 KB | ||
| 2013-02-04 07:57 |
Karolinska Development signs agreement with Mayo Clinic
|
English | 333.8 KB | ||
| 2013-01-30 07:57 |
Dilaforette – Phase II study with sevuparin for the treatment of severe malaria…
|
English | 347.9 KB | ||
| 2013-01-30 07:57 |
Dilaforette – Fas II-studie med sevuparin för behandling av svår malaria inledd
|
Swedish | 348.8 KB | ||
| 2012-12-21 08:28 |
Pergamum reports positive Phase II data from clinical trial in outer ear infect…
|
English | 346.2 KB | ||
| 2012-12-21 08:28 |
Pergamum rapporterar positiva fas II-data från klinisk studie vid infektioner i…
|
Swedish | 348.4 KB |
Automate Your Workflow. Get a real-time feed of all Karolinska Development filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Karolinska Development
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Karolinska Development via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-05-04 | Johan Dighed | Other | Buy | 35,000 | 56,350.00 SEK |
| 2023-03-27 | Johan Dighed | Other | Buy | 50,000 | 89,000.00 SEK |
| 2023-02-17 | Hans Christopher Karl Osvald Perbandt Toll | Other | Buy | 35,000 | 72,100.00 SEK |
| 2022-12-19 | Johan Dighed | Other | Buy | 50,000 | 83,500.00 SEK |
| 2022-09-30 | Johan Dighed | Other | Buy | 40,187 | 72,336.60 SEK |
| 2020-06-26 | Hans Lennart Rudolf Wigzell | Other | Buy | 9,014 | 25,780.04 SEK |
| 2020-06-26 | Hans Lennart Rudolf Wigzell | Other | Buy | 5,000 | 14,350.00 SEK |
| 2020-06-24 | Hans Lennart Rudolf Wigzell | Other | Buy | 9,276 | 26,529.36 SEK |
| 2020-06-24 | Hans Lennart Rudolf Wigzell | Other | Buy | 4,645 | 13,331.15 SEK |
| 2020-06-23 | Hans Lennart Rudolf Wigzell | Other | Buy | 39,702 | 111,562.62 SEK |
Peer Companies
